Total Payments
$593.56
2024 Payments
$73.10
Companies
7
Transactions
21
Medicare Patients
1,681
Medicare Billing
$151,292
Payment Breakdown by Category
Food & Beverage$593.56 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $593.56 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $222.11 | 5 | $0 (2021) |
| Shire North American Group Inc | $156.53 | 9 | $0 (2019) |
| OPTOS, INC. | $83.20 | 1 | $0 (2018) |
| Tarsus Pharmaceuticals, Inc. | $51.22 | 2 | $0 (2024) |
| Oyster Point Pharma, Inc. | $41.24 | 2 | $0 (2022) |
| Glaukos Corporation | $21.88 | 1 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $17.38 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $73.10 | 3 | Tarsus Pharmaceuticals, Inc. ($51.22) |
| 2022 | $58.62 | 3 | Oyster Point Pharma, Inc. ($41.24) |
| 2021 | $43.01 | 2 | Allergan, Inc. ($43.01) |
| 2020 | $12.15 | 1 | Allergan, Inc. ($12.15) |
| 2019 | $58.32 | 3 | Shire North American Group Inc ($58.32) |
| 2018 | $134.17 | 4 | OPTOS, INC. ($83.20) |
| 2017 | $214.19 | 5 | Allergan Inc. ($150.00) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/26/2024 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $21.88 | General |
| 02/20/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 01/30/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $31.56 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/12/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: DRY EYE | ||||||
| 08/03/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: DRY EYE | ||||||
| 05/03/2022 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), PROLENSA, LOTEMAX SM | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Ophthalmology | ||||||
| 02/16/2021 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/21/2021 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/03/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/04/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: OPTHALMICS | ||||||
| 02/04/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: OPTHALMICS | ||||||
| 02/04/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: OPTHALMICS | ||||||
| 12/11/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: OPTHALMICS | ||||||
| 09/06/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: OPTHALMICS | ||||||
| 08/24/2018 | OPTOS, INC. | Monaco (Device), P200T, California | Food and Beverage | Cash or cash equivalent | $83.20 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/30/2018 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/01/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: OPTHALMICS | ||||||
| 07/24/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: OPTHALMICS | ||||||
| 07/21/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: OPTHALMICS | ||||||
| 07/18/2017 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 06/14/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: OPTHALMICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 301 | 530 | $57,131 | $29,033 |
| 2022 | 9 | 371 | 603 | $65,901 | $35,522 |
| 2021 | 9 | 459 | 671 | $71,952 | $40,733 |
| 2020 | 8 | 550 | 832 | $80,027 | $46,003 |
Total Patients
1,681
Total Services
2,636
Medicare Billing
$151,292
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 288 | $37,440 | $21,112 | 56.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $3,515 | $1,966 | 55.9% |
| 92250 | Photography of the retina | Office | 2023 | 67 | 77 | $5,005 | $1,585 | 31.7% |
| 92134 | Imaging of retina | Office | 2023 | 30 | 56 | $3,640 | $1,374 | 37.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 26 | 32 | $2,656 | $1,155 | 43.5% |
| 92133 | Imaging of optic nerve | Office | 2023 | 35 | 45 | $2,925 | $1,016 | 34.7% |
| 92273 | Measurement of retinal and optic nerve function | Office | 2023 | 13 | 13 | $1,950 | $825.02 | 42.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 114 | 293 | $38,090 | $23,147 | 60.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $4,995 | $2,977 | 59.6% |
| 92273 | Measurement of retinal and optic nerve function | Office | 2022 | 25 | 29 | $4,350 | $2,177 | 50.0% |
| 92250 | Photography of the retina | Office | 2022 | 67 | 78 | $5,070 | $1,859 | 36.7% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 35 | 37 | $3,071 | $1,480 | 48.2% |
| 92134 | Imaging of retina | Office | 2022 | 33 | 56 | $3,640 | $1,476 | 40.6% |
| 92133 | Imaging of optic nerve | Office | 2022 | 41 | 53 | $3,445 | $1,191 | 34.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 15 | $2,550 | $752.78 | 29.5% |
| 92082 | Exam of visual field with intermediate testing | Office | 2022 | 15 | 15 | $690.00 | $462.84 | 67.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 142 | 308 | $39,671 | $24,809 | 62.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 25 | $4,250 | $3,309 | 77.9% |
| 92273 | Full field recording of retinal electrical responses to external stimuli with interpretation and report | Office | 2021 | 35 | 36 | $5,400 | $2,878 | 53.3% |
| 92250 | Photography of the retina | Office | 2021 | 90 | 100 | $6,488 | $2,374 | 36.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $4,230 | $2,045 | 48.3% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 49 | 68 | $4,364 | $1,849 | 42.4% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 39 | 42 | $3,486 | $1,674 | 48.0% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 40 | 51 | $3,225 | $1,191 | 36.9% |
| 92082 | Measurement of field of vision during daylight conditions, intermediate examination | Office | 2021 | 18 | 18 | $838.00 | $603.16 | 72.0% |
About Dr. Hernan Benavides, O.D
Dr. Hernan Benavides, O.D is a Optometrist healthcare provider based in Eufaula, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1053397703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hernan Benavides, O.D has received a total of $593.56 in payments from pharmaceutical and medical device companies, with $73.10 received in 2024. These payments were reported across 21 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($593.56).
As a Medicare-enrolled provider, Benavides has provided services to 1,681 Medicare beneficiaries, totaling 2,636 services with total Medicare billing of $151,292. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Eufaula, AL
- Active Since 12/15/2005
- Last Updated 07/06/2009
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1053397703
Products in Payments
- XIIDRA (Drug) $156.53
- Monaco (Device) $83.20
- LUMIGAN (Drug) $72.11
- XDEMVY (Drug) $51.22
- TYRVAYA (Drug) $41.24
- VYZULTA (Drug) $17.38
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.